2015
DOI: 10.1186/s13287-015-0178-y
|View full text |Cite
|
Sign up to set email alerts
|

Strategies to improve the immunosuppressive properties of human mesenchymal stem cells

Abstract: Mesenchymal stem cells (MSCs) are of particular interest for the treatment of immune-related diseases because of their immunosuppressive capacities. However, few clinical trials of MSCs have yielded satisfactory results. A number of clinical trials using MSCs are currently in progress worldwide. Unfortunately, protocols and methods, including optimized culture conditions for the harvest of MSCs, have not been standardized. In this regard, complications in the ex vivo expansion of MSCs and MSC heterogeneity hav… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
34
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(34 citation statements)
references
References 135 publications
(157 reference statements)
0
34
0
Order By: Relevance
“…There are evidences suggesting that MSCs produce immune modulatory and regenerative factors in response to inflammatory stimuli, in fact, it may be possible to enhance or suppress certain functions of MSCs by controlling their culture conditions, in particular, priming of MSCs with IFNγ and TNFα successfully improved their immunomodulatory functions 27 . Specifically, treatment with IFNγ up-regulated several genes involved in immunomodulation, such as HLA-DRA, CD274B7, IDO, VCAM1, ICAM2, and chemokines such as CCL8, CXCL9 and CXCL10 28 . In addition, an in vitro model showed that, after priming with TNFα plus IFNγ, MSCs were less potent at increasing cytokine production by activated PBMCs and more effective at inhibiting T-cell proliferation 29 .…”
Section: Discussionmentioning
confidence: 99%
“…There are evidences suggesting that MSCs produce immune modulatory and regenerative factors in response to inflammatory stimuli, in fact, it may be possible to enhance or suppress certain functions of MSCs by controlling their culture conditions, in particular, priming of MSCs with IFNγ and TNFα successfully improved their immunomodulatory functions 27 . Specifically, treatment with IFNγ up-regulated several genes involved in immunomodulation, such as HLA-DRA, CD274B7, IDO, VCAM1, ICAM2, and chemokines such as CCL8, CXCL9 and CXCL10 28 . In addition, an in vitro model showed that, after priming with TNFα plus IFNγ, MSCs were less potent at increasing cytokine production by activated PBMCs and more effective at inhibiting T-cell proliferation 29 .…”
Section: Discussionmentioning
confidence: 99%
“…Many studies referring to MSC tracing have demonstrated that intravenously engrafted MSCs are mostly intercepted by microvessels of the lung, heart, liver, kidney, etc., as well as homing to inflammatory and injured areas [1114]. Importantly, MSCs have been shown to have regenerative, anti-inflammatory, and immunomodulatory capabilities [1517]. Many experiments and early clinical trials have indicated that MSCs can block the rejection or even induce immune tolerance following transplantation [18, 19].…”
Section: Introductionmentioning
confidence: 99%
“…Since ECM/SVF-gel contains concentrated ECM components, it may likely serve as a stimulus for the robust inflammation response during the early stages of wound healing. In cytotherapeutic strategies, MSCs have recently been shown to have various immunomodulatory effects on host immune cells in both wound healing and transplant biology [ 45 – 48 ]. To release immunosuppressive factors, MSCs can downregulate the inflammatory response and move the wound past the state of persistent inflammation, conferring the cells with immune privilege and making them an attractive cell type for the treatment of chronic wounds [ 49 51 ].…”
Section: Discussionmentioning
confidence: 99%